ZVRA Competitors & Alternatives
Compare Zevra Therapeutics Inc. with similar stocks in the same industry
Biotechnology
ZVRA
Main Stock$10.06
Tradestie Score
55
Market Cap
$529.35M
P/E Ratio
4.7
Revenue Growth
0.8%
Analyst Upside
+148.6%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ERAS
Erasca, Inc. Common Stock
|
$17.84
|
$626.91M | - | 51 | Compare |
|
SVRA
Savara Inc.
|
$5.33
|
$611.84M | - | 58 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
MPLT
MPLT
|
$12.55
|
$590.40M | - | 51 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.17
|
$552.46M | - | 49 | Compare |
|
VSTM
Verastem, Inc.
|
$5.69
|
$541.60M | - | 53 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$13.37
|
$540.97M | - | 50 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$111.64
|
$522.78M | - | 51 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.33
|
$512.39M | - | 53 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$37.43
|
$505.12M | 1.9 | 58 | Compare |
More ZVRA Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry